Subscribe to RSS
Smith–Lemli–Opitz Mutations in Unexplained StillbirthsFunding This study was supported by grants (HD45925, HD45944, HD45952, HD45953, HD45954, and HD45925) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
15 November 2017
20 December 2017
12 February 2018 (online)
Objective Smith–Lemli–Opitz syndrome (SLOS) is an autosomal recessive syndrome caused by a defect in cholesterol biosynthesis with mutations in 7-dehydrocholesterol reductase (DHCR7). A total of 3% of Caucasians carry DHCR7 mutations, theoretically resulting in a homozygote frequency of 1/4000. However, SLOS occurs in only 1/20,000 to 60,000 live births. Our objective was to assess DHCR7 mutations in unexplained stillbirths.
Study Design Prospective, multicenter, population-based case–control study of all stillbirths and a representative sample of live births enrolled in five geographic areas. Cases with stillbirth due to obstetric complications, infection, or aneuploidy, and those with poor quality deoxyribonucleic acid (DNA) were excluded. DNA was extracted from placental tissue stored at –80°C, and exons 3 to 9 of the DCHR7 gene were amplified, purified, and subjected to bidirectional sequencing to identify mutations.
Results One-hundred forty four stillbirths were unexplained and had adequate DNA for analysis. Nine stillbirths of 139 (6.5%) had a single mutation in one allele in coding exons 3 to 9 of DHCR7 (Table 1). One case (0.7%) was a compound heterozygote for mutations in exons 3 to 9 of DHCR7; this fetus had no clinical or histologic features of SLOS.
Conclusion We detected SLOS mutations in only 0.7% of stillbirths. This does not support a strong association between unrecognized DHCR7 mutations and stillbirth.
The comments and views of the authors do not necessarily represent the views of the NICHD.
- 1 Quélin C, Loget P, Verloes A. , et al. Phenotypic spectrum of fetal Smith-Lemli-Opitz syndrome. Eur J Med Genet 2012; 55 (02) 81-90
- 2 Opitz JM, Gilbert-Barness E, Ackerman J, Lowichik A. Cholesterol and development: the RSH (“Smith-Lemli-Opitz”) syndrome and related conditions. Pediatr Pathol Mol Med 2002; 21 (02) 153-181
- 3 Opitz JM. A little cholesterol in time..... Clin Invest Med 2001; 24 (06) 318-320
- 4 Waye JS, Nakamura LM, Eng B. , et al. Smith-Lemli-Opitz syndrome: carrier frequency and spectrum of DHCR7 mutations in Canada. J Med Genet 2002; 39 (06) E31
- 5 Nowaczyk MJ, Nakamura LM, Eng B, Porter FD, Waye JS. Frequency and ethnic distribution of the common DHCR7 mutation in Smith-Lemli-Opitz syndrome. Am J Med Genet 2001; 102 (04) 383-386
- 6 Nowaczyk MJM, Waye JS. The Smith-Lemli-Opitz syndrome: a novel metabolic way of understanding developmental biology, embryogenesis, and dysmorphology. Clin Genet 2001; 59 (06) 375-386
- 7 Patrono C, Dionisi-Vici C, Giannotti A. , et al. Two novel mutations of the human delta7-sterol reductase (DHCR7) gene in children with Smith-Lemli-Opitz syndrome. Mol Cell Probes 2002; 16 (04) 315-318
- 8 Witsch-Baumgartner M, Ciara E, Löffler J. , et al. Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations. Eur J Hum Genet 2001; 9 (01) 45-50
- 9 Jira PE, Wanders RJ, Smeitink JA. , et al. Novel mutations in the 7-dehydrocholesterol reductase gene of 13 patients with Smith–Lemli–Opitz syndrome. Ann Hum Genet 2001; 65 (Pt 3): 229-236
- 10 Waterham HR, Hennekam RC. Mutational spectrum of Smith-Lemli-Opitz syndrome. Am J Med Genet C Semin Med Genet 2012; 160C (04) 263-284
- 11 Prasad C, Marles S, Prasad AN. , et al. Smith-Lemli-Opitz syndrome: new mutation with a mild phenotype. Am J Med Genet 2002; 108 (01) 64-68
- 12 Neklason DW, Andrews KM, Kelley RI, Metherall JE. Biochemical variants of Smith-Lemli-Opitz syndrome. Am J Med Genet 1999; 85 (05) 517-523
- 13 Battaile KP, Battaile BC, Merkens LS, Maslen CL, Steiner RD. Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome. Mol Genet Metab 2001; 72 (01) 67-71
- 14 Parker CB, Hogue CJ, Koch MA. , et al; Stillbirth Collaborative Research Network. Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatr Perinat Epidemiol 2011; 25 (05) 425-435
- 15 Stillbirth Collaborative Research Network Writing Group. Association between stillbirth and risk factors known at pregnancy confirmation. JAMA 2011; 306 (22) 2469-2479
- 16 Dudley DJ, Goldenberg R, Conway D. , et al; Stillbirth Research Collaborative Network. A new system for determining the causes of stillbirth. Obstet Gynecol 2010; 116 (2 Pt 1): 254-260
- 17 Hamilton BE, Martin JA, Osterman MJK, Curtin SC, Mathews TJ. National Vital Statistics Reports: Births: Final Data for 2014. Atlanta, GA: Centers for Disease Control and Prevention; 2015
- 18 MacDorman MF, Gregory ECW. National Vital Statistics Reports: Fetal and Perinatal Mortality: United States, 2013. Atlanta, GA: Centers for Disease Control and Prevention; 2015
- 19 Cross JL, Iben J, Simpson CL. , et al. Determination of the allelic frequency in Smith-Lemli-Opitz syndrome by analysis of massively parallel sequencing data sets. Clin Genet 2015; 87 (06) 570-575
- 20 Mills K, Mandel H, Montemagno R, Soothill P, Gershoni-Baruch R, Clayton PT. First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency). Pediatr Res 1996; 39 (05) 816-819
- 21 Schoen E, Norem C, O'Keefe J, Krieger R, Walton D, To TT. Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions. Obstet Gynecol 2003; 102 (01) 167-172
- 22 Abuelo DN, Tint GS, Kelley R, Batta AK, Shefer S, Salen G. Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols. Am J Med Genet 1995; 56 (03) 281-285
- 23 Linck LM, Hayflick SJ, Lin DS. , et al. Fetal demise with Smith-Lemli-Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7-dehydrocholesterol Delta(7)-reductase activity in chorionic villi. Prenat Diagn 2000; 20 (03) 238-240
- 24 Loeffler J, Utermann G, Witsch-Baumgartner M. Molecular prenatal diagnosis of Smith-Lemli-Opitz syndrome is reliable and efficient. Prenat Diagn 2002; 22 (09) 827-830
- 25 Löffler J, Trojovsky A, Casati B, Kroisel PM, Utermann G. Homozygosity for the W151X stop mutation in the delta7-sterol reductase gene (DHCR7) causing a lethal form of Smith-Lemli-Opitz syndrome: retrospective molecular diagnosis. Am J Med Genet 2000; 95 (02) 174-177